Navigating Effective Therapeutic Strategies for Dermatophytosis

Dermatophytosis, a common fungal skin infection, is a pressing global health issue, especially in underdeveloped regions where resistance to all antifungal classes is prevalent. While tinea infections are superficial, they can spread extensively, leading to significant socio-economic burdens and decreased quality of life. Early diagnosis and intervention are vital to combat resistance and recurrence. However, traditional topical antifungal therapies face challenges in penetrating and being retained by the skin, reducing their effectiveness. This review aims to explore innovative therapeutic strategies to enhance drug delivery for the treatment of dermatophytosis. Nanocarrier systems have emerged as a promising approach, with the potential to facilitate targeted delivery of antifungal drugs through the skin's natural barrier. Various nanocarriers, such as liposomes, niosomes and polymeric nanoparticles, have significant potential for delivering drugs with unstable physiochemical characteristics. Additionally, formulations combining antifungals with hydrating agents may significantly enhance topical therapy efficacy, particularly for recalcitrant infections associated with compromised skin barrier function. This comprehensive review will delve into the epidemiology and pathogenesis of dermatophytosis, with an emphasis on the potential of novel nanocarrier systems and optimized formulations to address the growing challenge of antifungal resistance in resource-limited settings. By exploring these advanced strategies, we can work towards improving treatment outcomes for dermatophytosis and alleviating the burden of these persistent infections.